![Alan Rubino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan Rubino
Direktor/Vorstandsmitglied bei VERICEL CORPORATION
Vermögen: 1 Mio $ am 30.06.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Harmel Rayat | M | 63 | 6 Jahre | |
Kevin Richardson | M | 54 | 19 Jahre | |
Michael F. Snape | M | - |
AMO Pharma Ltd.
![]() AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | 9 Jahre |
Joseph Mara | M | 49 | 3 Jahre | |
Stephen Sullivan | M | 77 | 20 Jahre | |
Robert Zerbe | M | 73 | 18 Jahre | |
Dominick Colangelo | M | 60 | 11 Jahre | |
Leonard Mazur | M | 79 |
Akrimax Pharmaceuticals LLC
![]() Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 16 Jahre |
Robert C. Getts | M | - |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
James M. Kadushin | M | - |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Heidi Hagen | F | 55 | 11 Jahre | |
Anthony Stolarski | M | 52 | 8 Jahre | |
Michael Halpin | M | 62 | 7 Jahre | |
Sean Flynn | M | 50 | 5 Jahre | |
Lisa M. Goldman | F | - |
HealthCare Institute of New Jersey
| 10 Jahre |
Saiyed Mahmood | M | 50 |
AMO Pharma Ltd.
![]() AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | - |
Steven Gilman | M | 71 | 9 Jahre | |
Kevin T. Rigby | M | - |
HealthCare Institute of New Jersey
| 12 Jahre |
Kevin McLaughlin | M | 67 | 9 Jahre | |
Lisa Wright | F | 49 | 3 Jahre | |
Julia Jones | F | - |
AMO Pharma Ltd.
![]() AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | 3 Jahre |
Paul Wotton | M | 63 | 9 Jahre | |
Jeffrey S. Sherman | M | 68 |
HealthCare Institute of New Jersey
| 10 Jahre |
Yin Becker | F | 60 |
HealthCare Institute of New Jersey
| 10 Jahre |
Phil Nikolayuk | M | - | 9 Jahre | |
Patrick J. Fowler | M | - | 3 Jahre | |
Roland DeAngelis | M | - | - | |
Raymond Sacchetti | M | - |
HealthCare Institute of New Jersey
| 10 Jahre |
Eric Burns | M | - | - | |
Julie Downs | F | - | - | |
Joseph Horrigan | M | - |
AMO Pharma Ltd.
![]() AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | - |
Peter Stegagno | M | 63 | 18 Jahre | |
Haskell Berman | M | - |
HealthCare Institute of New Jersey
| 13 Jahre |
Mark Trudeau | M | 62 |
HealthCare Institute of New Jersey
| - |
Vijay Aggarwal | M | 75 |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Anthony Hooper | M | 69 |
HealthCare Institute of New Jersey
| - |
John Chiminski | M | 60 |
HealthCare Institute of New Jersey
| - |
Jayne C. Gershkowitz | F | - |
HealthCare Institute of New Jersey
| - |
Tony H. Wild | M | 75 |
HealthCare Institute of New Jersey
| - |
S. Arieh Zak | M | 59 |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Jo Schweinle | M | - | 4 Jahre | |
Wendy M. Lazarus | F | - |
HealthCare Institute of New Jersey
| - |
Steve Issenman | M | - |
HealthCare Institute of New Jersey
| 13 Jahre |
Cynthia L. Sullivan | F | 68 |
HealthCare Institute of New Jersey
| 15 Jahre |
Patrick Zenner | M | 77 |
HealthCare Institute of New Jersey
| - |
Iulian Cioanta | M | 60 | 17 Jahre | |
Neil Larimer | M | - |
Akrimax Pharmaceuticals LLC
![]() Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 14 Jahre |
John C. Simons | M | - |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Charles S. Lachman | M | - |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Russ Fein | M | - |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Caryn Cramer-Babycz | F | - | 13 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sydney Colin Neill | M | 77 | 6 Jahre | |
Michael R. Garone | M | 66 | 9 Jahre | |
Lisa Sundstrom | F | 54 | - | |
Michael W. Elliston | M | - | - | |
Tim Mayleben | M | 63 | 8 Jahre | |
James Marino | M | 74 |
Rutgers State University of New Jersey
| 10 Jahre |
Michael Schuler | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
Brian D. Gibson | M | 45 | 3 Jahre | |
Barry J. Jenkins | M | 61 | 6 Jahre | |
Scott Durbin | M | 55 | 1 Jahre | |
Kaiyo Nedd | M | 50 | 1 Jahre | |
Gerald D. Brennan | M | 73 | 4 Jahre | |
Nelson M. Sims | M | 76 | 9 Jahre | |
R. Douglas Armstrong | M | 70 | 19 Jahre | |
Joseph J. Krivulka | M | 73 |
Akrimax Pharmaceuticals LLC
![]() Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 11 Jahre |
James A. Meer | M | 78 | 2 Jahre | |
Christopher M. Cashman | M | 56 | 3 Jahre | |
James Andrew Cour | M | 68 | 2 Jahre | |
Tod Borton | M | - | - | |
Bernard Laurel | M | - | - | |
Sharon M. Watling | M | 60 | - | |
Maj-Britt Kaltoft | M | 61 | 4 Jahre | |
Anthony Evnin | M | 83 | 6 Jahre | |
Carl Sailer | M | 54 |
Akrimax Pharmaceuticals LLC
![]() Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 10 Jahre |
Jeffrey Heller | M | - |
Rutgers State University of New Jersey
| 6 Jahre |
Kenneth Kirkland | M | 82 | 8 Jahre | |
Michael J. Farrell | M | 45 |
New American Therapeutics, Inc.
![]() New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ.
Akrimax Pharmaceuticals LLC
![]() Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 4 Jahre |
Patsy J. Trisler | F | 74 | 6 Jahre | |
Kathleen McDede | F | - | - | |
Gerard Michel | M | 60 | 6 Jahre | |
Thomas Price | M | 68 | 1 Jahre | |
Thomas J. Cafferty | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
Saul Zimmerman | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
Jonathan M. Kuller | M | - |
Rutgers State University of New Jersey
| 8 Jahre |
George Dunbar | M | 77 | 4 Jahre | |
Bryan B. Sendrowski | M | - |
Akrimax Pharmaceuticals LLC
![]() Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ
New American Therapeutics, Inc.
![]() New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | 4 Jahre |
Douglas B. Campbell | M | - |
Rutgers State University of New Jersey
| 6 Jahre |
Douglas A. Duchak | M | - |
Rutgers State University of New Jersey
| 5 Jahre |
John Fritzen Nemelka | M | 59 | 13 Jahre | |
Srini Akkaraju Akkaraju | M | 56 | 5 Jahre | |
Allan Harvey Cohen | M | 73 |
Rutgers State University of New Jersey
| 5 Jahre |
Alan E. Delahoy | M | - |
Rutgers State University of New Jersey
| 4 Jahre |
Thomas H. Robinson | M | 65 | 7 Jahre | |
William Joseph Daley | M | - |
Rutgers State University of New Jersey
| 5 Jahre |
Joseph Chiarelli | M | 77 | 1 Jahre | |
Bob Cook | M | 68 | 1 Jahre | |
Robert M. Pickus | M | 70 |
Rutgers State University of New Jersey
| 7 Jahre |
Ronald M. Cresswell | M | 89 | 4 Jahre | |
Ronald Sparks | M | 69 | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 96 | 96,00% |
Vereinigtes Königreich | 4 | 4,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Alan Rubino
- Persönliches Netzwerk